Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Nicole Massoll

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPathology, College of Medicine
DivisionPathology Clinical
AddressC1-5108 Cancer Institute
4104 Outpatient Circle
Mail Slot # 604
Little Rock AR 72205
Phone501-526-5611
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    RSG-17-028-01-CSM     (MASSOLL, NICOLE A)Jul 1, 2017 - Jun 30, 2018
    American Cancer Society, Inc.
    Tumor-stromal crosstalk in papillary thyroid cancer- Resubmission
    Role: Co-Investigator
    RSG     (MACNICOL, ANGUS)Mar 1, 2002 - Feb 28, 2006
    American Cancer Society, Inc.
    MRNA translational Control of Cell Cycle Progression
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Jeffus SK, Chen C, Keskin T, Massoll N, Korourian S, Allard F. Entrustable professional activities for cytopathology fellowship. J Am Soc Cytopathol. 2024 Oct 24. PMID: 39567307.
      View in: PubMed
    2. Branigan GP, Casado-Medrano V, O'Neill AB, Ricarte-Filho JC, Massoll N, Salwen M, Spangler Z, Scheerer M, Williamson EK, Bauer AJ, Franco AT. Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics. Cancers (Basel). 2023 Jan 31; 15(3). PMID: 36765847.
      View in: PubMed
    3. Finkelstein SD, Sistrunk JW, Malchoff C, Thompson DV, Kumar G, Timmaraju VA, Repko B, Mireskandari A, Evoy-Goodman LA, Massoll NA, Lupo MA. A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules. Thyroid. 2022 11; 32(11):1362-1371. PMID: 35943886.
      View in: PubMed
    4. Caperton CO, Jolly LA, Massoll N, Bauer AJ, Franco AT. Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer. Cancers (Basel). 2021 Mar 04; 13(5). PMID: 33806425.
      View in: PubMed
    5. Lupo MA, Walts AE, Sistrunk JW, Massoll N, Campbell R, Jackson SA, Toney N, Narick CM, Kumar G, Mireskandari A, Finkelstein SD, Bose S. Reply to Letter to the Editor by William Gooding and Simion Chiosea: Alternate diagnostic test interpretation in a retrospective convenience cohort and clinical application of MPTX. Diagn Cytopathol. 2021 02; 49(2):349-350. PMID: 33236830.
      View in: PubMed
    6. Ciarletto AM, Narick C, Malchoff CD, Massoll NA, Labourier E, Haugh K, Mireskandari A, Finkelstein SD, Kumar G. Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples. Cancer Cytopathol. 2021 03; 129(3):239-249. PMID: 33017868.
      View in: PubMed
    7. Lupo MA, Walts AE, Sistrunk JW, Giordano TJ, Sadow PM, Massoll N, Campbell R, Jackson SA, Toney N, Narick CM, Kumar G, Mireskandari A, Finkelstein SD, Bose S. Multiplatform molecular test performance in indeterminate thyroid nodules. Diagn Cytopathol. 2020 Dec; 48(12):1254-1264. PMID: 32767735.
      View in: PubMed
    8. Kumarapeli AR, Bellamy W, Olgaard E, Massoll N, Korourian S. Short-Duration Rapid Chilling of Mastectomy Specimens Does Not Interfere With Breast Cancer Biomarker and Molecular Testing. Arch Pathol Lab Med. 2019 01; 143(1):92-98. PMID: 29932859.
      View in: PubMed
    9. Hinson AM, Massoll NA, Jolly LA, Stack BC, Bodenner DL, Franco AT. Structural alterations in tumor-draining lymph nodes before papillary thyroid carcinoma metastasis. Head Neck. 2017 08; 39(8):1639-1646. PMID: 28467685.
      View in: PubMed
    10. Jolly LA, Massoll N, Franco AT. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss. J Clin Cell Immunol. 2016 Oct; 7(5). PMID: 27942419.
      View in: PubMed
    11. Jolly LA, Novitskiy S, Owens P, Massoll N, Cheng N, Fang W, Moses HL, Franco AT. Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. Cancer Res. 2016 04 01; 76(7):1804-13. PMID: 26818109.
      View in: PubMed
    12. Meena N, Jeffus S, Massoll N, Siegel ER, Korourian S, Chen C, Bartter T. Rapid onsite evaluation: A comparison of cytopathologist and pulmonologist performance. Cancer Cytopathol. 2016 Apr; 124(4):279-84. PMID: 26492064.
      View in: PubMed
    13. Jeffus SK, Joiner AK, Siegel ER, Massoll NA, Meena N, Chen C, Post SR, Bartter T. Rapid on-site evaluation of EBUS-TBNA specimens of lymph nodes: Comparative analysis and recommendations for standardization. Cancer Cytopathol. 2015 Jun; 123(6):362-72. PMID: 25931443.
      View in: PubMed
    14. Johnston M, Winham W, Massoll N, Gardner JM. Observation of a unique case of metastatic basal cell carcinoma found by radiographic evaluation in a patient with oculocutaneous albinism. F1000Res. 2014; 3:10. PMID: 24555117.
      View in: PubMed
    15. Sims JR, Massoll NA, Suen JY. Herpes simplex infection of the larynx requiring laryngectomy. Am J Otolaryngol. 2013 May-Jun; 34(3):236-8. PMID: 23332410.
      View in: PubMed
    16. Ucar DA, Kurenova E, Garrett TJ, Cance WG, Nyberg C, Cox A, Massoll N, Ostrov DA, Lawrence N, Sebti SM, Zajac-Kaye M, Hochwald SN. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth. Cell Cycle. 2012 Sep 01; 11(17):3250-9. PMID: 22894899.
      View in: PubMed
    17. Zheng D, Golubovskaya V, Kurenova E, Wood C, Massoll NA, Ostrov D, Cance WG, Hochwald SN. A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts. Mol Carcinog. 2010 Feb; 49(2):200-9. PMID: 19885860.
      View in: PubMed
    18. Hochwald SN, Nyberg C, Zheng M, Zheng D, Wood C, Massoll NA, Magis A, Ostrov D, Cance WG, Golubovskaya VM. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer. Cell Cycle. 2009 Aug; 8(15):2435-43. PMID: 19571674.
      View in: PubMed
    19. Kurenova EV, Hunt DL, He D, Fu AD, Massoll NA, Golubovskaya VM, Garces CA, Cance WG. Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo. Cell Cycle. 2009 Jul 15; 8(14):2266-80. PMID: 19556880.
      View in: PubMed
    20. Li, C, Grobmyer, SR, Massoll, NA, Liang, X, Zhang, Q, Chen, L, Fajardo, LL, Jiang, H. Noninvasive in vivo tomographic optical imaging of cellular morphology in the breast: possible convergence of microscopic pathology and macroscopic radiology. Med Phys. 2008; 35(6):2493-501.
    21. Beierle, EA, Massoll, NA, Hartwich, J, Kurenova, EV, Golubovskaya, VM, Cance, WG, McGrady, P, London, WB. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analysis. Clin Cancer Res. 2008; 14(11):3299-305.
    22. Beierle EA, Massoll NA, Hartwich J, Kurenova EV, Golubovskaya VM, Cance WG, McGrady P, London WB. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses. Clin Cancer Res. 2008 Jun 01; 14(11):3299-305. PMID: 18519756.
      View in: PubMed
    23. Yoder BJ, Rufforny I, Massoll NA, Wilkinson EJ. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol. 2008 May; 32(5):765-72. PMID: 18379417.
      View in: PubMed
    24. Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR, Cance WG. p53 regulates FAK expression in human tumor cells. Mol Carcinog. 2008 May; 47(5):373-82. PMID: 17999388.
      View in: PubMed
    25. Redman R, Rufforny I, Liu C, Wilkinson EJ, Massoll NA. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix. Arch Pathol Lab Med. 2008 May; 132(5):795-9. PMID: 18466028.
      View in: PubMed
    26. Ai L, Kim WJ, Demircan B, Dyer LM, Bray KJ, Skehan RR, Massoll NA, Brown KD. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008 Mar; 29(3):510-8. PMID: 18174247.
      View in: PubMed
    27. Morozov VM, Massoll NA, Vladimirova OV, Maul GG, Ishov AM. Regulation of c-met expression by transcription repressor Daxx. Oncogene. 2008 Apr 03; 27(15):2177-86. PMID: 17952115.
      View in: PubMed
    28. Wilson JP, Massoll N, Marshall J, Foss RM, Copeland EM, Grobmyer SR. Idiopathic granulomatous mastitis: in search of a therapeutic paradigm. Am Surg. 2007 Aug; 73(8):798-802. PMID: 17879688.
      View in: PubMed
    29. Yoder BJ, Wilkinson EJ, Massoll NA. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J. 2007 Mar-Apr; 13(2):172-9. PMID: 17319859.
      View in: PubMed
    30. Bui A, Mazzaferri E, Massoll N. Cystic papillary thyroid cancer. Thyroid. 2006 Dec; 16(12):1319-20. PMID: 17199445.
      View in: PubMed
    31. Redman R, Yoder BJ, Massoll NA. Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid. 2006 Oct; 16(10):1003-8. PMID: 17042686.
      View in: PubMed
    32. Redman, R, Yoder, BJ, Massoll, NA. Perceptions of diagnostic terminology and cytopathologic reporting f fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid. 2006; 16(10):1003-8.
    33. Ai L, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res. 2006 Aug 15; 66(16):7899-909. PMID: 16912163.
      View in: PubMed
    34. Yoder BJ, Redman R, Massoll NA. Validation of a five-tier cytodiagnostic system for thyroid fine needle aspiration biopsies using cytohistologic correlation. Thyroid. 2006 Aug; 16(8):781-6. PMID: 16910881.
      View in: PubMed
    35. Ai, L, Kim, WJ, Kim, TY, Fields, CR, Massoll, NA, Robertson, KD, Brown, KD. Epigenetic silencing of the tumor suppressor cystatin M occurs during beast cancer progression. Cancer Res. 2006; 15(66):7899-909.
    36. Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006 Jan; 16(1):55-60. PMID: 16487014.
      View in: PubMed
    37. Redman R, Wilkinson EJ, Massoll NA. Uterine-like mass with features of an extrauterine adenomyoma presenting 22 years after total abdominal hysterectomy-bilateral salpingo-oophorectomy: a case report and review of the literature. Arch Pathol Lab Med. 2005 Aug; 129(8):1041-3. PMID: 16048397.
      View in: PubMed
    38. Redman R, Wilkinson, EJ, Massoll, NA. Uterine-like mass with features of an extrauterine adenomyoma presenting 22 years after total abdominal hysterectomy-bilateral salpingo-oohorectomy: a case report and review of the literature. Arch Pathol Lab Med. 2005; 129(8):1041-3.
    39. Drew PA, Hong B, Massoll NA, Ripley DL. Characterization of papillary squamotransitional cell carcinoma of the cervix. J Low Genit Tract Dis. 2005 Jul; 9(3):149-53. PMID: 16044054.
      View in: PubMed
    40. Redman R, Massoll NA, Wilkinson EJ. Association between invasive squamous cell carcinoma of the vulva and ABO blood group. J Low Genit Tract Dis. 2005 Apr; 9(2):89-92. PMID: 15870529.
      View in: PubMed
    41. Rufforny I, Wilkinson EJ, Liu C, Zhu H, Buteral M, Massoll NA. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma. J Low Genit Tract Dis. 2005 Apr; 9(2):108-13. PMID: 15870532.
      View in: PubMed
    42. Massoll N, Mazzaferri EL. Diagnosis and management of medullary thyroid carcinoma. Clin Lab Med. 2004 Mar; 24(1):49-83. PMID: 15157557.
      View in: PubMed
    43. Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer. 2002 Dec; 9(4):227-47. PMID: 12542401.
      View in: PubMed
    44. Massoll NA, Wilkinson EJ. Lipogranuloma of the cervix. J Low Genit Tract Dis. 2002 Oct; 6(4):218-9. PMID: 17051025.
      View in: PubMed
    45. Lamps LW, Madhusudhan KT, Greenson JK, Pierce RH, Massoll NA, Chiles MC, Dean PJ, Scott MA. The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study. Am J Surg Pathol. 2001 Apr; 25(4):508-15. PMID: 11257626.
      View in: PubMed
    46. Pappas AA, Massoll NA, Cannon DJ. Toxicology: past, present, and future. Ann Clin Lab Sci. 1999 Oct-Dec; 29(4):253-62. PMID: 10528824.
      View in: PubMed
    Massoll's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (242) concept(s)
    _
    Co-Authors Expand Description
    See all (9) people
    _
    Similar People Expand Description
    See all (37) people
    _
    Same Department Expand Description
    Search Department